Randal J. Kirk

Description

R.J. Kirk is Chairman and Chief Executive Officer of Intrexon, a leading synthetic biology technology company. Mr. Kirk was named Chairman ...

Investor Profile

Randal J. Kirk has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

• Series F (33%)
• Series E (33%)
• Post Ipo Equity (33%)

Country Focus

• 
  United States (100%)

Industry Focus

• Biotechnology
• Life Science
• Medical
• Therapeutics